BIOMAT Database Logo BIOMAT Database Logo

Topical application of fumaric acid derivatives. 1995

U H Schmid

UI MeSH Term Description Entries
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D005650 Fumarates Compounds based on fumaric acid. Fumarate,Fumaric Acid Ester,Fumaric Acid Esters,Fumarate Esters,Acid Ester, Fumaric,Acid Esters, Fumaric,Ester, Fumaric Acid,Esters, Fumarate,Esters, Fumaric Acid
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069462 Dimethyl Fumarate A fumarate derivative that is used as a DERMATOLOGIC AGENT in the treatment of PSORIASIS and SKIN DISEASES. It also may be used as an IMMUNOSUPPRESSIVE AGENT in the treatment of MULTIPLE SCLEROSIS. 2-butenedioic acid, (2E)-, dimethyl ester,BG 00012,BG 12 compound,BG-00012,BG-12 compound,BG00012,BG12 compound,Dimethylfumarate,FAG 201,FAG-201,FAG201,Fumaderm,Tecfidera,00012, BG,12 compound, BG,201, FAG,Fumarate, Dimethyl,compound, BG 12,compound, BG12
D000279 Administration, Cutaneous The application of suitable drug dosage forms to the skin for either local or systemic effects. Cutaneous Drug Administration,Dermal Drug Administration,Drug Administration, Dermal,Percutaneous Administration,Skin Drug Administration,Transcutaneous Administration,Transdermal Administration,Administration, Dermal,Administration, Transcutaneous,Administration, Transdermal,Cutaneous Administration,Cutaneous Administration, Drug,Dermal Administration,Drug Administration, Cutaneous,Skin Administration, Drug,Administration, Cutaneous Drug,Administration, Dermal Drug,Administration, Percutaneous,Administrations, Cutaneous,Administrations, Cutaneous Drug,Administrations, Dermal,Administrations, Dermal Drug,Administrations, Percutaneous,Administrations, Transcutaneous,Administrations, Transdermal,Cutaneous Administrations,Cutaneous Administrations, Drug,Cutaneous Drug Administrations,Dermal Administrations,Dermal Drug Administrations,Drug Administrations, Cutaneous,Drug Administrations, Dermal,Drug Skin Administrations,Percutaneous Administrations,Skin Administrations, Drug,Skin Drug Administrations,Transcutaneous Administrations,Transdermal Administrations
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations

Related Publications

U H Schmid
[Application of fumaric acid derivatives in psoriasis].
December 1990, Nederlands tijdschrift voor geneeskunde,
U H Schmid
The risk of sensibilization and contact urticaria upon topical application of fumaric acid derivatives.
January 1994, Dermatology (Basel, Switzerland),
U H Schmid
[The nephrotoxic effect of fumaric acid derivatives].
March 1991, Deutsche medizinische Wochenschrift (1946),
U H Schmid
[Kidney damage caused by fumaric acid derivatives].
May 1988, Nederlands tijdschrift voor geneeskunde,
U H Schmid
[Systemic treatment of psoriasis by fumaric acid derivatives].
January 1996, Annales de dermatologie et de venereologie,
U H Schmid
New derivatives of fumaric acid as plant growth regulators.
January 2001, Doklady. Biochemistry and biophysics,
U H Schmid
[Peroral long-term treatment of psoriasis using fumaric acid derivatives].
May 1987, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete,
U H Schmid
Bioadhesive topical application of tryptophan derivatives.
January 2003, Advances in experimental medicine and biology,
U H Schmid
[Acute kidney failure during psoriasis therapy with fumaric acid derivatives].
June 1990, Deutsche medizinische Wochenschrift (1946),
U H Schmid
Non-invasive assessment of the antipsoriatic activity of fumaric acid derivatives.
August 1995, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI),
Copied contents to your clipboard!